نتائج البحث 1031-1040 من 19155 لعملية البحث عن HIV/AIDS
This phase II trial studies how well inotuzumab ozogamicin works in treating younger patients with CD22 positive B acute lymphoblastic leukemia that has come ...
The purpose of this study is to evaluate the safety and effectiveness of MK-1026 (formerly ARQ 531) in participants with hematologic malignancies of chronic ...
... for Pathological Response in Stage II-III HER2-positive Breast Cancer. Scottsdale/Phoenix, Ariz., Jacksonville, Fla., Rochester, Minn. The purpose of this ...
The purpose of this study is to collect blood samples for DNA analysis from patients clinically diagnosed with Alzheimers disease, Lewy Body disease, and ...
A Study to Evaluate Regional Radiotherapy in Biomarker Low-Risk Node Positive ... Iberdomide, Daratumumab, Bortezomib, and Dexamethasone for Treatment of Newly ...
... and ovarian cancer) cancer-specific methylated DNA markers and high-risk human papilloma virus (HR-HPV) detected in vaginal fluid and/or plasma. Hematology ...
This phase II trial studies how well inotuzumab ozogamicin works in treating younger patients with CD22 positive B acute lymphoblastic leukemia that has ...
... infection, length of hospital stay, and readmission rates. Phase 1/2 Study ... for analysis of exploratory and future tumor biomarkers for individualized ...
... of relapsed myeloma and the effect of the treatments on the quality-of-life measurements. ... Positive Relapsed or Refractory AML, MRD Positive AML or Higher Risk ...
The purpose of this study is to evaluate the use of a smartphone app for stroke patients with obstructive sleep apnea in order to better use their positive ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.